Division of GI/Hepatology, University of California, San Francisco, San Francisco, CA, USA.
Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
J Hepatol. 2020 Sep;73(3):516-522. doi: 10.1016/j.jhep.2020.03.049. Epub 2020 Jun 9.
BACKGROUND & AIMS: The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear. METHODS: Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension. RESULTS: Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7-8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3-5% vs. 6%), and preterm birth (5-7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death. CONCLUSION: The prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care. LAY SUMMARY: The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.
背景与目的:非酒精性脂肪性肝病(NAFLD)在年轻成年人中的发病率正在上升,这可能对生育年龄的妇女产生影响。妊娠期间的 NAFLD 是否会对产妇或围产期健康造成更严重的风险尚不清楚。
方法:我们利用美国国家住院患者样本的加权出院数据,评估了妊娠 20 周后 NAFLD 的时间趋势,并将其结果与其他慢性肝病(CLD)或无 CLD 的妊娠进行了比较。研究结果包括早产、产后出血、高血压并发症(子痫前期、子痫和/或溶血、肝酶升高和血小板减少症)以及产妇或胎儿死亡。通过日历年来估计 NAFLD 的患病率,并通过线性回归来检验时间趋势。通过逻辑回归分析对年龄、种族、多胎妊娠以及孕前糖尿病、肥胖、血脂异常和高血压进行调整,对结果进行分析。
结果:在 18574225 例妊娠中,5640 例有 NAFLD,115210 例有其他非 NAFLD 的 CLD。NAFLD 妊娠的比例从 2007 年的 10.5/100000 例增加到 2015 年的 28.9/100000 例,几乎增加了两倍(p<0.001)。与其他组相比,妊娠期间患有 NAFLD 的患者更常发生妊娠期糖尿病(7-8% vs. 23%)、高血压并发症(4% vs. 16%)、产后出血(3-5% vs. 6%)和早产(5-7% vs. 9%),所有 p 值均≤0.01。在调整分析中,与无 CLD 相比,NAFLD 与高血压并发症、早产、产后出血和可能的产妇(而非胎儿)死亡相关。
结论:在过去十年中,妊娠中 NAFLD 的患病率几乎增加了两倍,与高血压并发症、早产和产后出血独立相关。NAFLD 应被视为一种高危产科情况,对孕前咨询和妊娠护理具有临床意义。
非医学背景的普通人理解起来可能会有一些困难,如果你有任何问题,请随时提问。
Am J Gastroenterol. 2022-3-1
Hepatology. 2022-1
Am J Obstet Gynecol. 2021-5
EClinicalMedicine. 2025-5-9
Beijing Da Xue Xue Bao Yi Xue Ban. 2025-6-18
J Clin Invest. 2025-5-15
Nat Rev Dis Primers. 2019-7-11
Nat Rev Nephrol. 2019-5
Clin Gastroenterol Hepatol. 2018-6-14
Nat Rev Cardiol. 2017-10-12